Kelly Timothy Edwin 4
4 · Praxis Precision Medicines, Inc. · Filed Nov 19, 2024
Insider Transaction Report
Form 4
Kelly Timothy Edwin
Chief Financial Officer
Transactions
- Award
Common Stock
2024-11-14$37.40/sh+205$7,667→ 12,345 total
Footnotes (1)
- [F1]These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).